Guardant Health
GH
#981
Rank
HK$192.22 B
Marketcap
HK$1,432
Share price
2.54%
Change (1 day)
160.29%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

ESG Reports

Thumbnail Guardant Health
 ESG Report 2024

ESG Report 2024

Language: English

View ESG Report
Thumbnail Guardant Health
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report